Showing results (821-830 of 2,857) with videos related to

Sort By:
Pageof 286
Pathology Oncology Research : POR|July 9, 1998
Cytokine sensitivity of metastatic human melanoma cell lines-- simultaneous inhibition of proliferation and enhancement of gelatinase activityA Ladányi, J O Nagy, A Jeney, et al.
Pathology Oncology Research : POR|July 9, 1998
Role for glucose transporter 1 protein in human breast cancerM Grover-McKay, S A Walsh, E A Seftor, et al.
Pathology Oncology Research : POR|May 30, 2020
Co-Expression of Mesothelin and CA125 Is Associated with the Poor Prognosis of Endometrial Serous Carcinoma and Mixed Carcinomas Including Serous CarcinomaSoichiro Kakimoto, Morikazu Miyamoto, Takahiro Einama, et al.
Pathology Oncology Research : POR|May 30, 2020
Identification of Novel Candidate Biomarkers for Oral Squamous Cell Carcinoma Based on Whole Gene Expression ProfilingSudaporn Kengkarn, Songsak Petmitr, Usa Boonyuen, et al.
Pathology Oncology Research : POR|June 30, 2015
Correlation of High Mobility Group Box-1 Protein (HMGB1) with Clinicopathological Parameters in Primary RetinoblastomaMithalesh Kumar Singh, Lata Singh, Neelam Pushker, et al.
Pathology Oncology Research : POR|May 25, 2015
Characterization of Individuals Taking Part in Low Dose Computed Tomography (LDCT) Screening ProgramMariann Moizs, Gábor Bajzik, Zsuzsanna Lelovics, et al.
Pathology Oncology Research : POR|October 26, 2019
LncRNA HEIH Enhances Paclitaxel-Tolerance of Endometrial Cancer Cells via Activation of MAPK Signaling PathwayJun-Liang Guo, Tian Tang, Jin-Hong Li, et al.
Pathology Oncology Research : POR|June 20, 2020
In Vivo Detection of CTC and CTC Plakoglobin Status Helps Predict Prognosis in Patients with Metastatic Breast CancerNing Xie, Zheyu Hu, Can Tian, et al.
Pathology Oncology Research : POR|June 22, 2020
Comparison of Nottingham Prognostic Index, PREDICT and PrognosTILs in Triple Negative Breast Cancer -a Retrospective Cohort StudyAnita Sejben, Tibor Nyári, Tamás Zombori, et al.
Pathology Oncology Research : POR|August 12, 2016
Variations in EGFR ctDNA Correlates to the Clinical Efficacy of Afatinib in Non Small Cell Lung Cancer with Acquired ResistanceJinfeng He, Wei Tan, Xuelian Tang, et al.
Pageof 286